Features
Few cancer genes are more notorious than the genes that cause familial breast cancer—BRCA1 and BRCA2. The New York Times described the cloning of BRCA1 in 1994 as "a genetic trophy so ferociously coveted and loudly heralded that it had taken on a near-mythic aura," but cautioned that since the gene was unexpectedly large, it might take at least a year before a diagnostic test could be developed from it. Read the full story »
Partners in Science:
The Umbrella CRADA Streamlines Collaborations Between CCR and Industry
Researchers across CCR are studying the molecular mechanisms that underlie multiple diseases. Read more about CCR's partners in science »
Nitric Oxide:
Just say NO to Cancer and Much More
Blood vessels use it to relax, neurons use it to communicate, and innate immune cells use it to kill dangerous invaders. Read more about nitric oxide (NO) »
Inflammation:
Where immune Cells and Blood Vessels Collide
In an average person, there are approximately 20,000,000,000 neutrophils patrolling the bloodstream on the lookout for trouble. Read more about immune cells »
News
A Cure for the Incurable?
Using the Body's Immune System to Treat Metastatic Cancers
Small RNAs Play a Big Role in Cancer Biology
Targeted Destruction:Novel Interactions in Ubiquitylation and Tumorigenesis
Recent CCR Awards:View the new 2009 CCR awards
Keeping Cell Suicide in Check:Understanding how TRAIL activates apoptosis in cancer cells
Brain Cancers:Not All Made the Same
In Conversation:Research Fellow Aaron Schetter, Ph. D., M.P.H.
Staff News at CCRStaff announcements and new tenure-track scientists at CCR